54 Azithromycin to Reduce Maternal Infections in Planned Vaginal Birth: Secondary Analysis of the A-PLUS Trial

The intrapartum azithromycin trial (A-PLUS Trial) showed a reduction in maternal sepsis or death mainly driven by sepsis. To test the hypothesis that a single oral dose of intrapartum 2g azithromycin (AZI) in women in labor planning a vaginal delivery reduces the incidence of any maternal infection
Source: American Journal of Obstetrics and Gynecology - Category: OBGYN Authors: Tags: Oral Concurrent Session 5 - Medical & Surgical Complications Source Type: research